Sirtex appoints new CEO
Thursday, 26 May, 2005
Sydney biomedical company Sirtex Medical (ASX:SRX) has promoted Gilman Wong from chief operating officer to chief executive officer.
Wong only joined Sirtex in February 2005 but chairman Bruce Gray said that he "has made a substantial contribution to company activities since then."
Wong has a strong background in sales and marketing -- a potentially useful background for Sirtex, whose sales revenue last year grew 8 per cent to $4.9 million, but whose gross profit fell to $3.57 million from $3.6 million in 2003.
Wong has held senior management positions in the manufacturing, engineering and automotive industries.
Noxopharm says paper reveals science behind its immune system platform
Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...
Neurosensing/neurostimulation implants session to be held on Monday
On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...
argenx and Monash University partner against autoimmune diseases
To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...
